Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Protagen, Vela in Bio-Comparability Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Protagen, Vela in Bio-Comparability Pact

Collaboration will aid in biologic, biosimilar development

Vela Laboratories, a provider GMP-compliant potency and release testing, and Protagen AG, a  specialist in the characterization of protein drugs, have formed a strategic alliance in customer based analytics and marketing & sales.

“The fast-growing demand for comparability of biologics needs creative steps and business models,” said Dr. Markus Fido, chief executive officer of Vela. “Protagen and Vela are internationally renowned and well-established contract research labs for complete characterization of biopharmaceuticals and biosimilars, and both companies belong to the leading providers of ICH-compliant analytical services. Our customers will benefit from this alliance through more efficient project work and study design.”

“The technology portfolio and the exceptional expertise of VELA in the area of bioassays for potency determination of therapeutic antibodies, growth factors and protein hormones, will synergistically complement the experience and competences of Protagen. Our customers in the pharmaceutical and biotech sector, as well as CROs and CMOs, will profit from this alliance through the direct access to a comprehensive service portfolio,” said Dr. Stefan Müllner, Protagen’s chief executive officer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters